ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
C1orf50 | Chromosome 1 open reading frame 50 | Predicted membrane proteins
| | | | | Expressed in all |
CD47 | CD47 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CLN6 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
DERL2 | Derlin 2 | Predicted membrane proteins
| | | | | Expressed in all |
EBP | Emopamil binding protein (sterol isomerase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KIAA0195 | KIAA0195 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
MFSD11 | Major facilitator superfamily domain containing 11 | Predicted membrane proteins
| | | | | Expressed in all |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
NRM | Nurim (nuclear envelope membrane protein) | Predicted membrane proteins
| | | | | Expressed in all |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
RHBDL1 | Rhomboid, veinlet-like 1 (Drosophila) | Enzymes Predicted membrane proteins
| | | | | Mixed |
SCD | Stearoyl-CoA desaturase (delta-9-desaturase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SFXN1 | Sideroflexin 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC15A4 | Solute carrier family 15 (oligopeptide transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A20 | Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35B3 | Solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC39A14 | Solute carrier family 39 (zinc transporter), member 14 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
SLC41A3 | Solute carrier family 41, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SYVN1 | Synovial apoptosis inhibitor 1, synoviolin | Predicted membrane proteins
| | | | | Expressed in all |
TECR | Trans-2,3-enoyl-CoA reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
TMEM164 | Transmembrane protein 164 | Predicted membrane proteins
| | | | | Expressed in all |
TMEM201 | Transmembrane protein 201 | Predicted membrane proteins
| | | | | Mixed |
TMEM87A | Transmembrane protein 87A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
TSPO | Translocator protein (18kDa) | Cancer-related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
YIF1A | Yip1 interacting factor homolog A (S. cerevisiae) | Predicted membrane proteins
| | | | | Expressed in all |
YIPF3 | Yip1 domain family, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
YIPF4 | Yip1 domain family, member 4 | Predicted membrane proteins
| | | | | Expressed in all |